¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"interstitial density"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interstitial implant
    Á¶Á÷³»À̽Ű
  • interstitial implantation
    »çÀÌÁúÂø»ó, °£ÁúÂø»ó
  • interstitial irradiation
    Á¶Á÷³»Á¶»ç
  • interstitial lamella
    »çÀÌÃþÆÇ, °£ÁúÆÇ
  • interstitial lung disease
    »çÀÌÁúÆóÁúȯ, °£Áú¼ºÆóÁúȯ
  • interstitial mastitis
    °£ÁúÀ¯¹æ¿°, »çÀÌÁúÀ¯¹æ¿°
  • interstitial nephritis
    »çÀÌÁúÄáÆÏ¿°, °£Áú½ÅÀå¿°
  • interstitial nucleus
    »çÀÌÁúÇÙ, °£ÁúÇÙ
  • interstitial opacity
    »çÀÌÁúȥŹ, °£ÁúȥŹ
  • interstitial pancreatitis
    »çÀÌÁúÀÌÀÚ¿°, °£ÁúÃéÀå¿°
  • interstitial plasma cell pneumonia
    »çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • interstitial pregnancy
    »çÀÌÁúÀÓ½Å, Àڱú®ÀڱðüÀÓ½Å
  • interstitial salpingitis
    1. »çÀÌÁúÀڱðü¿°, °£Áú³­°ü¿° 2. »çÀÌÁú±Í°ü¿°, °£ÁúÀ̰ü¿°
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interstitial implantation
    ÀڱðüÀڱúκÐÂø»ó, ³­°üÀڱúκÐÂø»ó
  • interstitial irradiation
    Á¶Á÷³»¹æ»ç¼±Á¶»ç
  • interstitial lamella
    »çÀÌÃþÆÇ
  • interstitial mastitis
    °£ÁúÀ¯¹æ¿°, »çÀÌÁúÀ¯¹æ¿°
  • interstitial nephritis
    »çÀÌÁúÄáÆÏ¿°
  • interstitial nucleus
    »çÀÌÁúÇÙ
  • interstitial opacity
    »çÀÌÁúȥŹ
  • interstitial pancreatitis
    °£ÁúÀÌÀÚ¿°
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • interstitial pregnancy
    Àڱú®ÀڱðüÀÓ½Å, »çÀÌÁúÀÓ½Å
  • interstitial salpingitis
    »çÀÌÁúÀڱðü¿°
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • interstitial fluid pressure
    °£Áú¾×¾Ð·Â
  • luetic interstitial keratitis
    ¸Åµ¶»çÀÌÁú°¢¸·¿°
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
  • HDL (High-density lipoproteins)
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High-density lipoprotein = HDL
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • REM density
    ·½¹Ðµµ
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • amorphous density
    ¹«Á¤Çü ¹Ðµµ(ÙíïÒúþ ÚËÓø)
  • apparent density
    °Ñº¸±â ¹Ðµµ.
  • grain density
    ÀÔÀÚ<±×·¡ÀÎ>¹Ðµµ.
  • high electron density
    °íÀüÀڹеµ(ÍÔï³í­ÚËöô).
  • high-density lipoprotein
    °í¹ÐµµÁö¹æ´Ü¹é
  • incidence density
    ¹ß»ý ºóµµ
  • innervation density
    ½Å°æÁö¹è¹Ðµµ(¡­ÚËöô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interstitial cell stimulating hormone =ICSH
    °£Áú¼¼Æ÷ÀÚ±Ø(¡­ô§Ð½)È£¸£ ¸ó.
  • interstitial compound
    °£ÁúÈ­ÇÕ¹°.
  • interstitial connective tissue
    °£Áú°áÇÕÁ¶Á÷.
  • interstitial cusp
    °³Àç°áÀý(Ë¿î¤Ì¿ï½).
  • interstitial cystitis
    °£Áú¼º ¹æ±¤¿°.
  • interstitial deletion
    Á¶Á÷³»°á¼Õ
  • interstitial denticle
    °³À缺 »ó¾Æ¸³(Ë¿î¤àõßÚä³í£).
  • interstitial disease
    °£Áú¼º Áúȯ<º´>.
  • interstitial emphysema
    °£Áú¼º ±âÁ¾(ÊàòõàõѨðþ).
  • interstitial fluid =ISF
    °£Áú¾×(Êàòõäû), Á¶Á÷°£¾×.
  • interstitial gingivitis
    °£Áú¼º Ä¡Àº¿°(¡­öÍó»æú).
  • interstitial gland
    °£Áú¼±(ÊàòõàÍ).
  • interstitial growth
    °£Áú¼ºÀå(¡­à÷íþ).
  • interstitial growth
    »çÀÌÁú¼ºÀå
  • interstitial hernia
    º¹º®±Ù°£(º¹º®±Ù°£)Ç츣´Ï¾Æ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exponential density gradient
    Áö¼ö ³óµµ ±¸¹è (ò¦â¦ÒØÓøÎøÛÎ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
  • optical density
    Èí±¤µµ(ýåÎÃÓø)
  • sucrose density gradient
    ½´Å©·Î½º ¹Ðµµ ±¸¹è(ÚËÓøÎøÛÎ)
  • superhelix density
    Ãʳª¼± ¹Ðµµ (õ±Õ¢àÁÚËÓø)
  • very high-density lipoprotein
    Ãʰí¹Ðµµ(õ±ÍÔÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-density lipoprotein
    ÃÊÀú¹Ðµµ (õ±î¸ÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • electron density
    ÀüÀڹеµ
  • flux density
    À¯µ¿¹Ðµµ
  • linear density
    ¼±»óÀ½¿µ
  • magnetic flux density
    ÀÚ±âÀ¯µ¿¹Ðµµ
  • middle density
    Áß°£À½¿µ, Áß°£¹Ðµµ
  • nodular density
    °áÀý¼ºÀ½¿µ
  • perihilar density
    Æó¹®ÁÖÀ§À½¿µ
  • pixel density
    Çȼ¿À½¿µ, È­¼ÒÀ½¿µ
  • proton (spin) density
    ¾çÀڹеµ
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton density weighting
    ¾çÀÚ°­Á¶
  • reticular density
    ¸Á»óÀ½¿µ
  • shadow density
    À½¿µ¹Ðµµ
  • spin density
    ½ºÇɹеµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IDL Intermediate Density Lipoprotein; Á߹еµ ÁöÁú ´Ü¹éÁú
LDL Low Density Lipoprotein; Àú¹Ðµµ ÁöÁú ´Ü¹éÁú
VLDL Very Low Density Lipoprotein
AO abdominal aorta; achievement orientation; acid output; acridine orange; ankle orthosis; anodal openi...
Bd board; buoyant density
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ILP Interstitial Laser Photocoagulation
ILD Interstitial Lung Disease
IP Interstitial Pneumonitis
IC Interstitial cells
ICC Interstitial cells of Cajal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renomedullary interstitial cell tomor
    ½Å ¼öÁú °£Áú ¼¼Æ÷Á¾ Á¾¾ç
  • syphilitic interstitial keratitis
    ¸Åµ¶¼º ½ÇÁú °¢¸·¿°
  • tubulo-interstitial disease
    ¼¼´¢°ü-°£Áú¼º Áúȯ
  • absolute density
    Àý´ë ¹Ðµµ
  • asymmetric density
    ºñ´ëμº À½¿µ
  • bone density
    °ñ ¹Ðµµ
  • density
    ¹Ðµµ, ÈæÈ­µµ, À½¿µ, ³óµµ
    1. ¹ÐÁýÇϰí ÀÖ´Â ¾ç. 2. ¾î´À ÀÏÁ¤ üÀûÀÇ ¹°ÁúÀÇ ¾ç. 3. Àü±â¹°µµ, Àü·ù¹Ðµµ : ¾î´À ÀÏÁ¤ÇÑ ¸éÀû, üÀû, ½Ã°£³»ÀÇ Àü±âÀÇ ¾ç. 4. ³ë±¤ÀÌ µÇ¾î Çö»óµÈ »çÁø, ¶Ç´Â x¼± Çʸ§ÀÇ Èæ»ö ³óµµ. Çʸ§ÀÇ ÀÏÁ¤ ¸éÀû °ªÀÇ ´ë¼ö·Î¼­ Ç¥½ÃÇÑ´Ù. 5. Áú·® ¹Ðµµ¸¦ ÀǹÌÇÏ¸ç ´ÜÀ§ üÀû´ç Áú·®À» ¸»ÇÑ´Ù.
  • density gradient centrifugation
    ¹Ðµµ±¸¹è ¿ø½É¹ý
    ÃÊ¿ø½É ħ°­ ÆòÇü¹ýÀÇ ÀÀ¿ëÀÌ¸ç Æ¯È÷ »ýü °íºÐÀÚ°èÀÇ ¿¬±¸¿¡ »ç¿ëµÇ´Â ¹æ¹ý. ÀúºÐÀÚÀÇ ¿ë¾×ÀÌ¶óµµ ÃÊ¿ø½É·ÂÀå¿¡ Àå½Ã°£ ³õÀ¸¸é ÀúºÐÀÚÀÇ ³óµµ ºÐÆ÷¿¡ ħ°­ ÆòÇüÀÌ ¹ß»ýÇÏ°í ¾×¸é¿¡¼­ ¹Ø¹Ù´ÚÀ» ÇâÇÏ¿© ³óµµ¸¦ Áõ°¡½ÃÄÑ ÀÏÁ¤ÇÑ ¹Ðµµ °æ»ç°¡ »ý±ä´Ù. ÀÌ ¿ë¾×¿¡ °íºÐÀÚ°¡ Á¸ÀçÇÏ¸é °íºÐÀÚÀÇ Ä§°­°ú È®»êÀÌ ±ÕÇüÀÌ ÀâÈù ħ°­ ÆòÇü°ú µ¿½Ã¿¡ °íºÐÀÚÀÇ ¿ë¾× ³» ¹Ðµµ¿Í ¿ë¸ÅÀÇ ¹Ðµµ°¡ °°Àº Á¸ÀçÇÏ°Ô µÈ´Ù. ±× À§Ä¡¿¡¼­ °íºÐÀÚÀÇ ¿ë¾× ³» ¹Ðµµ¿Í ¿ë¸ÅÀÇ ¹Ðµµ°¡ °°Àº À§Ä¡¿¡ ºÐÀÚ°¡ ÁýÁßÇÏ¿© Á¸ÀçÇÏ°Ô µÈ´Ù. ±× À§Ä¡¿¡¼­ °íºÐÀÚÀÇ ¿ë¾× ¼Ó¿¡¼­ÀÇ ºÎÀ¯ ¹Ðµµ¸¦ ±¸ÇÒ ¼ö ÀÖ°í ±× À§Ä¡¸¦ Áß½ÉÀ¸·Î ÇÑ ³óµµ ºÐÆ÷ÀÇ È®»ê¿¡¼­ ºÐÀÚ·®À» ±¸ÇÒ ¼ö ÀÖ´Ù.
  • density scale
    ³óµµ ´«±Ý
  • electron density
    ÀüÀÚ ¹Ðµµ
    ÀüÀÚÇö¹Ì°æ¿¡¼­ ÀüÀÚÀÇ Åõ°ú¸¦ ¸·À» ¼ö ÀÖ´Â µÎ²² ¶Ç´Â ¹Ðµµ.
  • energy flux density
    ¿¡³ÊÁö¼Ó ¹Ðµµ
  • equilibrium density gradient centrifugation
    ÆòÇü ¹Ðµµ ±¸¹è ¿ø½É¹ý
  • high electron density
    °íÀüÀÚ ¹Ðµµ
    ÀüÀÚµéÀÇ ¹Ðµµ°¡ ³ôÀº °÷.
  • high-density lipoprotein
    °í¹Ðµµ Áö¹æ ´Ü¹é
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
density-dependent <epidemiology> 1. Effects whose intensity changes with increasing population density.
2. Effects whose intensity increases with increasing population density, for example a mortality which becomes very high near a carrying capacity. Effects which become less pronounced at higher population sizes (perhaps the reduction in fecundity caused by the difficulty of mating) are sometimes called inverse density dependent. Density dependent effects are often a cause of nonlinearity in a model.
(05 Dec 1998)
density dependent inhibition of growth <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached.
The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent.
(12 Jan 1998)
density gradient <chemistry> A column of liquid in which the density varies continually with position, usually as a consequence of variation of concentration of a solute.
Such gradients may be established by progressive mixing of solutions of different density as for example: sucrose gradients) or by centrifuge induced redistribution of solute (as for caesium chloride gradients).
Density gradients are widely used for centrifugal and gravity induced separations of cells, organelles and macromolecules. The separations may exploit density differences between particles or primarily differences in size, in which latter case the function of the gradient is chiefly to stabilise the liquid column against mixing.
(12 Jan 1998)
density gradient centrifugation <technique> High-speed centrifugation inwhich molecules float at a point wheretheir density equals that in a gradient of cesium chloride or sucrose.
(12 Jan 1998)
incidence density The person-time incidence rate.
(05 Mar 2000)
intermediate density lipoprotein Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins.
(05 Mar 2000)
inverse density dependence <epidemiology> See density dependence.
(05 Dec 1998)
optical density 1. <chemistry, investigation> Absorbance is defined as a logarithmic function of the percent transmission of a wavelength of light through a liquid.
2. <microbiology> This can be used as a measure of the amount of light absorbed by a suspension of bacterial cells or a solution of an organic molecule, it is measured by a colourimeter or spectrophotometer.
Absorbance values are used to plot the growth of bacteria in suspension cultures and to gauge the purity and concentration of molecules (such as proteins) in solution.
See: absorption.
(15 Jan 1998)
organismal density <microbiology> Number of organisms or items per unit area or volume.
(09 Oct 1997)
either particle flux density The particle fluence rate, or energy flux density, the energy fluence rate of intensity.
Compare: fluence.
(05 Mar 2000)
familial high density lipoprotein deficiency Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance.
Synonym: familial high {density lipoprotein deficiency}, Tangier disease.
Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood
(05 Mar 2000)
flux density <radiobiology> Total amount of a quantity passing through a unit surface area in unit time
See: flux.
(09 Oct 1997)
low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats in the bloodstream.
High levels of low density lipoprotein are considered a positive risk factor for the development of coronary artery disease. Less than 130 mg/dl is desirable, 130 to 159 mg/dl is borderline high, over 160 is considered high.
Acronym: LDL
(10 Jan 1998)
low density lipoprotein receptor <biochemistry> A cell surface protein that mediates the endocytosis of low density lipoprotein by cells.
Genetic defects in low density lipoprotein receptors lead to abnormal serum levels of low density lipoprotein and hypercholesterolaemia.
(16 Mar 1998)
low-density lipoprotein receptors Receptors on the surface of cells, especially liver cells, which bind to low density lipoprotein and promote clearance of LDL from the plasma.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á